John Hilterman/LinkedIn
Nov 5, 2025, 05:09
Rethinking Anticoagulants in Hospice
John Hilterman, Business Development Manager at Wise Hospice Option, posted on LinkedIn:
”Safer care starts with clearer insight.
For many hospice patients, the goal shifts from prevention to comfort – and that means re-evaluating medications like anticoagulants and antiplatelets.
Our latest Hospice Pharmacist’s Brief outlines when deprescribing is clinically appropriate, how to manage risk, and ways to align therapy with quality-of-life goals.”
Read more here.
Keep up with Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation